GTS Securities’s Alpine Immune Sciences Inc ALPN Stock Holding History

GTS Securities’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,900	Closed	-$313K	–	4445
2024 Q1	$313K	Buy	+7,900	New	+$233K	﹤0.01%	2960

GTS Securities's ALPN Position: Q2 2024 in Review

GTS Securities sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 8,499 shares — an estimated $337K sold.

GTS Securities first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $337K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

GTS Securities reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
GTS Securities sold 8,499 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $337K.
GTS Securities first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
GTS Securities's Alpine Immune Sciences Inc position peaked at $337K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on GTS Securities's 13F filing for Q2 2024, filed 14 Aug 2024.